• DENTSPLY SIRONA recently reported fourth-quarter 2025 results showing sales of US$961 million and a net loss of US$146 million, recorded sizeable non-cash impairment charges tied to weaker demand in key technology and implant segments, issued 2026 net sales guidance of US$3.5–3.6 billion, and announced board additions plus an expanded technology distribution partnership with Burkhart Dental Supply.
• These updates together reveal a company working to realign underperforming businesses, broaden access to its digital dentistry portfolio, and bring fresh financial expertise onto the board while still contending with loss-making operations and lower-than-expected volumes in important product categories.
• We'll now consider how the recent impairment charges in Orthodontic and Implant Solutions affect DENTSPLY SIRONA's existing investment narrative.

Uncover the next big thing with 30 elite penny stocks that balance risk and reward.

DENTSPLY SIRONA Investment Narrative Recap

To own DENTSPLY SIRONA, you need to believe its digital dentistry and implants businesses can eventually turn persistent losses into sustainable cash generation. Right now, the key short term catalyst is whether management can stabilize volumes in high-margin technology and implant categories, while the biggest risk is further write-downs if demand stays soft. The latest US$144 million non-cash impairments and continued net losses make that risk feel more immediate, but do not yet rewrite the core thesis.

The expanded partnership with Burkhart Dental Supply looks particularly relevant against this backdrop. By putting the full technology portfolio, including CEREC and Primescan systems, into a broader distribution channel, DENTSPLY SIRONA is trying to support adoption of its digital workflows at a time when volumes in equipment and implants are under pressure. How effectively this arrangement translates into better utilization of the installed base will be important for assessing near term progress on the thesis.

Yet beneath these growth efforts, the risk of more goodwill and intangible impairments is something investors should be aware of as...

DENTSPLY SIRONA's narrative projects $3.9 billion revenue and $502.2 million earnings by 2028.

Uncover how DENTSPLY SIRONA's forecasts yield a $12.97 fair value, a 4% downside to its current price.

Exploring Other Perspectives

Some of the lowest ranked analysts were already assuming flat revenue near US$3.8 billion and only modest earnings of about US$349 million, which is a more pessimistic story than the consensus narrative and may have to be revisited after another round of impairments and softer U.S. demand.

Explore 4 other fair value estimates on DENTSPLY SIRONA - why the stock might be worth over 3x more than the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your DENTSPLY SIRONA research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free DENTSPLY SIRONA research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate DENTSPLY SIRONA's overall financial health at a glance.

Interested In Other Possibilities?

Our top stock finds are flying under the radar-for now. Get in early:

• The future of work is here. Discover the 32 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• Find 47 companies with promising cash flow potential yet trading below their fair value.
• Rare earth metals are the new gold rush. Find out which 29 stocks are leading the charge.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.